Skip to main content
Premium Trial:

Request an Annual Quote

UK's MRC Selects Geneservice as Preferred Supplier for DNA Sequencing

NEW YORK (GenomeWeb News) - UK's Medical Research Council has selected Geneservice as one of three preferred sequencing service providers for its 35 research sites, the company said today.


Under the contract, Geneservice will be a preferred supplier for three years. MRC scientists will work with the company's DNA sequencing team.


According to Roger Turner, a director with the company, Geneservice has been providing DNA sequencing services to some of the sites for several years.


Launched in August 2005 following a management buyout of the UK Medical Research Council Biological Resource Center, the privately owned company employs around 30 people.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.